Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity

By afschroeder • September 22, 2025

Siddiqi TJ, Khan MS, Waqas SA, Van Spall HGC, Shapiro MD, Fonarow GC, Januzzi JL, Afzal AM, Pandey A, Butler J, Greene SJ. Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity. Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70048. Epub ahead of print. PMID: 40977256.

Tags: Cardiology/Epi, Chronic kidney disease, diabetes, GLP‐1 receptor agonists, heart failure, Obesity, Publications

Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with 177Lu-PSMA: A Retrospective, Single-Center Study

Murthy V, Kimura K, Theus L, Nguyen A, Lokre O, Perk T, Thin P, Nguyen K, Ludwig V, Chen L, Gafita A, Czernin J, Calais[...]

Associations of Plasma Trimethylamine N-Oxide-Related Metabolites with the Development and Progression of Albuminuria: The Multi-Ethnic Study of Atherosclerosis

Wang M, Tang WHW, Li XS, de Oliveira Otto MC, Lemaitre RN, Fretts A, Nemet I, Sotoodehnia N, Sitlani CM, Budoff M, DiDonato JA, Wang[...]

Methadone Blockade of Inward Rectifier Potassium Current Promotes Both Early and Delayed Repolarization Arrhythmias: Mechanistic Insights From Computational Modeling

Zhang Z, Green JT, Haigney MC, Walker P, Shivkumar K, Garfinkel A, Qu Z. Methadone Blockade of Inward Rectifier Potassium Current Promotes Both Early and[...]